These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34764984)

  • 41. Validating
    Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
    Front Oncol; 2021; 11():720302. PubMed ID: 34527588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma.
    Jiang J; Lu Y; Zhang F; Pan T; Zhang Z; Wan Y; Ren X; Zhang R
    BMC Cancer; 2022 Jun; 22(1):632. PubMed ID: 35676688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Zhao J; Cheng M; Gai J; Zhang R; Du T; Li Q
    Front Genet; 2020; 11():588499. PubMed ID: 33244319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD.
    Wang Z; Tian Z; Song X; Zhang J
    BMC Immunol; 2022 Jan; 23(1):1. PubMed ID: 34998385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
    Shen E; Han Y; Cai C; Liu P; Chen Y; Gao L; Huang Q; Shen H; Zeng S; He M
    Aging (Albany NY); 2021 Mar; 13(5):7570-7588. PubMed ID: 33658393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
    Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
    J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low UPB1 Level Correlates With Poor Prognosis in Lung Adenocarcinoma.
    Zhang L; Liu J; Wang H; Xu Z; Wang Y; Chen Y; Peng H
    Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):44-52. PubMed ID: 37859333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 50. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma.
    Du M; Liang Y; Liu Z; Li X; Liang M; Zhou B; Gao Y
    Front Oncol; 2021; 11():693353. PubMed ID: 34650911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression.
    Wang H; Gao J; Zhang R; Li M; Peng Z; Wang H
    Int Immunopharmacol; 2020 Jun; 83():106478. PubMed ID: 32278132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 54. SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
    Liu G; Li F; Chen M; Luo Y; Dai Y; Hou P
    Front Genet; 2022; 13():813285. PubMed ID: 35356432
    [No Abstract]   [Full Text] [Related]  

  • 55. Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated With Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers.
    Shi J; Chen Y; Wang Z; Guo J; Tong C; Tong J; Hu W; Li C; Li X
    Front Oncol; 2021; 11():712795. PubMed ID: 34692489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma.
    Zhou CS; Feng MT; Chen X; Gao Y; Chen L; Li LD; Li DH; Cao YQ
    Onco Targets Ther; 2021; 14():1033-1048. PubMed ID: 33623391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
    Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
    BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.